{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:28:32Z","timestamp":1790270912588,"version":"4.1.0"},"reference-count":28,"publisher":"Wiley","issue":"11-12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Galectin Therapeutics Inc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1111\/apt.13816","type":"journal-article","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T03:26:48Z","timestamp":1477366008000},"page":"1183-1198","source":"Crossref","is-referenced-by-count":167,"title":["Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis"],"prefix":"10.1111","volume":"44","author":[{"given":"S. A.","family":"Harrison","sequence":"first","affiliation":[{"name":"Fort Sam Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. R.","family":"Marri","sequence":"additional","affiliation":[{"name":"Indianapolis IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Chalasani","sequence":"additional","affiliation":[{"name":"Indianapolis IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kohli","sequence":"additional","affiliation":[{"name":"Cincinnati OH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Aronstein","sequence":"additional","affiliation":[{"name":"Cincinnati OH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. A.","family":"Thompson","sequence":"additional","affiliation":[{"name":"West Chester OH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Irish","sequence":"additional","affiliation":[{"name":"Cincinnati OH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. V.","family":"Miles","sequence":"additional","affiliation":[{"name":"Cincinnati OH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A.","family":"Xanthakos","sequence":"additional","affiliation":[{"name":"Cincinnati OH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Lawitz","sequence":"additional","affiliation":[{"name":"San Antonio TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Noureddin","sequence":"additional","affiliation":[{"name":"Los Angeles CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. D.","family":"Schiano","sequence":"additional","affiliation":[{"name":"New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"Richmond VA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sanyal","sequence":"additional","affiliation":[{"name":"St. Louis MO USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. A.","family":"Neuschwander-Tetri","sequence":"additional","affiliation":[{"name":"St. Louis MO USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. G.","family":"Traber","sequence":"additional","affiliation":[{"name":"Norcross GA USA"},{"name":"Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,10,24]]},"reference":[{"key":"10.1111\/apt.13816-BIB0001|apt13816-cit-0001","doi-asserted-by":"crossref","first-page":"7842","DOI":"10.1021\/bi201121m","article-title":"When galectins recognize glycans: from biochemistry to physiology and back again","volume":"50","author":"DiLella","year":"2011","journal-title":"Biochemistry"},{"key":"10.1111\/apt.13816-BIB0002|apt13816-cit-0002","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1073\/pnas.0511167103","article-title":"Galectin-3 regulates myofibroblast activation and hepatic fibrosis","volume":"103","author":"Henderson","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/apt.13816-BIB0003|apt13816-cit-0003","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1164\/rccm.201106-0965OC","article-title":"Regulation of transforming growth factor-beta1-driven lung fibrosis by galectin-3","volume":"185","author":"MacKinnon","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/apt.13816-BIB0004|apt13816-cit-0004","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2353\/ajpath.2008.070726","article-title":"Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis","volume":"172","author":"Henderson","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1111\/apt.13816-BIB0005|apt13816-cit-0005","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jhep.2010.09.020","article-title":"Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver","volume":"54","author":"Iacobini","year":"2011","journal-title":"J Hepatol"},{"key":"10.1111\/apt.13816-BIB0006|apt13816-cit-0006","doi-asserted-by":"crossref","first-page":"959824","DOI":"10.1100\/2012\/959824","article-title":"Deficiency in galectin-3 promotes hepatic injury in CDAA diet-induced nonalcoholic fatty liver disease","volume":"2012","author":"Nomoto","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"10.1111\/apt.13816-BIB0007|apt13816-cit-0007","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/path.2065","article-title":"Disrupted galectin-3 causes non-alcoholic fatty liver disease in male mice","volume":"210","author":"Nomoto","year":"2006","journal-title":"J Pathol"},{"key":"10.1111\/apt.13816-BIB0008|apt13816-cit-0008","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2119\/molmed.2014.00178","article-title":"Galectin-3 ablation enhances liver steatosis, but attenuates Inflammation and IL-33-dependent fibrosis in obesogenic mouse model of nonalcoholic steatohepatitis","volume":"21","author":"Jeftic","year":"2015","journal-title":"Mol Med"},{"key":"10.1111\/apt.13816-BIB0009|apt13816-cit-0009","doi-asserted-by":"crossref","first-page":"e83481","DOI":"10.1371\/journal.pone.0083481","article-title":"Therapy of experimental NASH and fibrosis with galectin inhibitors","volume":"8","author":"Traber","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1111\/apt.13816-BIB0010|apt13816-cit-0010","doi-asserted-by":"crossref","first-page":"e75361","DOI":"10.1371\/journal.pone.0075361","article-title":"Regression of fibrosis and reversal of cirrhosis in rats by galectin inhibitors in thioacetamide-induced liver disease","volume":"8","author":"Traber","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1111\/apt.13816-BIB0011|apt13816-cit-0011","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials","volume":"152","author":"Schulz","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1111\/apt.13816-BIB0012|apt13816-cit-0012","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrgastro.2010.21","article-title":"Pathology of nonalcoholic fatty liver disease","volume":"7","author":"Brunt","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1111\/apt.13816-BIB0013|apt13816-cit-0013","first-page":"9","volume-title":"Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring","author":"Jusko","year":"1986"},{"key":"10.1111\/apt.13816-BIB0014|apt13816-cit-0014","volume-title":"Pharmacokinetics","author":"Gibaldi","year":"1975"},{"key":"10.1111\/apt.13816-BIB0015|apt13816-cit-0015","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/j.1552-4604.1967.tb00290.x","article-title":"Drug accumulation","volume":"7","author":"Wagner","year":"1967","journal-title":"J Clin\u00a0Pharmacol J New Drugs"},{"key":"10.1111\/apt.13816-BIB0016|apt13816-cit-0016","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/hep.23797","article-title":"High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis","volume":"52","author":"Kohli","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/apt.13816-BIB0017|apt13816-cit-0017","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/apt.13816-BIB0018|apt13816-cit-0018","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.clinbiochem.2011.05.015","article-title":"Serum galectin-3 levels in patients with nonalcoholic fatty liver disease","volume":"44","author":"Yilmaz","year":"2011","journal-title":"Clin Biochem"},{"key":"10.1111\/apt.13816-BIB0019|apt13816-cit-0019","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1210\/jc.2009-1619","article-title":"Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes","volume":"95","author":"Weigert","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/apt.13816-BIB0020|apt13816-cit-0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/apt.12820","article-title":"Review article: the efficacy of biomarkers in chronic fibroproliferative diseases - early diagnosis and prognosis, with liver fibrosis as an exemplar","volume":"40","author":"Karsdal","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.13816-BIB0021|apt13816-cit-0021","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-230X-7-40","article-title":"Meta-analyses of FibroTest diagnostic value in chronic liver disease","volume":"7","author":"Poynard","year":"2007","journal-title":"BMC Gastroenterol"},{"key":"10.1111\/apt.13816-BIB0022|apt13816-cit-0022","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2013.05.015","article-title":"Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C","volume":"59","author":"Poynard","year":"2013","journal-title":"J Hepatol"},{"key":"10.1111\/apt.13816-BIB0023|apt13816-cit-0023","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-230X-6-6","article-title":"Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"6","author":"Ratziu","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1111\/apt.13816-BIB0024|apt13816-cit-0024","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jhep.2012.04.025","article-title":"Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population","volume":"57","author":"Poynard","year":"2012","journal-title":"J Hepatol"},{"key":"10.1111\/apt.13816-BIB0025|apt13816-cit-0025","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1007\/BF02087661","article-title":"Alpha-2-macroglobulin and hepatic fibrosis. Diagnostic interest","volume":"39","author":"Naveau","year":"1994","journal-title":"Dig Dis Sci"},{"key":"10.1111\/apt.13816-BIB0026|apt13816-cit-0026","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1423-0127-17-58","article-title":"Novel biomarkers predict liver fibrosis in hepatitis C patients: alpha 2 macroglobulin, vitamin D binding protein and apolipoprotein AI","volume":"17","author":"Ho","year":"2010","journal-title":"J Biomed Sci"},{"key":"10.1111\/apt.13816-BIB0027|apt13816-cit-0027","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/jcp.24266","article-title":"Alpha-2-Macroglobulin: a physiological guardian","volume":"228","author":"Rehman","year":"2013","journal-title":"J Cell Physiol"},{"key":"10.1111\/apt.13816-BIB0028|apt13816-cit-0028","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cccn.2004.06.015","article-title":"Comparison of coenzyme Q10 plasma levels in obese and normal weight children","volume":"349","author":"Menke","year":"2004","journal-title":"Clin Chim Acta"}],"container-title":["Alimentary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapt.13816","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/apt.13816\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T17:21:06Z","timestamp":1625419266000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.13816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,24]]},"references-count":28,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2016,12]]}},"URL":"https:\/\/doi.org\/10.1111\/apt.13816","archive":["Portico"],"relation":{},"ISSN":["0269-2813"],"issn-type":[{"value":"0269-2813","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10,24]]}}}